Used in Australia - Background on Propaganda Article: Measles-Mumps-Rubella-Varicella (MMRV) Vaccine Effective Alone or in Comb...]

[Guest guest]

From Meryl Dorey, AVN, Australia

Please note – this vaccine is CURRENTLY being used in Australia as part

of the schedule. Once again, little Australia is used as a testing zone

for the drug lords. If we don’t protest against this crap being pumped

into our kids, it will happen everywhere. Australia is asleep at the

wheel – so you will see it elsewhere very soon.

From: Sheri Nakken

[

mailto:vaccineinfo@...]

Sent: Monday, June 02, 2008 7:01 AM

To: Recipient list suppressed

Subject: Background on Propaganda Article:

Measles-Mumps-Rubella-Varicella (MMRV) Vaccine Effective Alone or in

Comb...]

http://www.cdc.gov/MMWR/preview/mmwrhtml/mm5710a3.htm

The preliminary results indicated a rate of febrile seizure of nine per

10,000 vaccinations among MMRV vaccine recipients compared with four per

10,000 vaccinations among MMR vaccine and varicella vaccine recipients

(adjusted odds ratio = 2.3; 95% confidence interval [CI] = 1.6--3.2;

p<0.0001). These results suggest that, in the 7--10 day

postvaccination period, approximately one additional febrile seizure

would occur among every 2,000 children vaccinated with MMRV vaccine,

compared with children vaccinated with MMR vaccine and varicella vaccine

administered at the same visit. Of the 166 children who experienced

febrile seizures after vaccination and had hospitalization information

available, 26 (16%) were hospitalized. No child who had a febrile

seizure died.

Â

Availability of MMRV vaccine currently is limited in the United States

because of manufacturing constraints unrelated to vaccine safety or

efficacy

(9

). MMRV vaccine is not expected to be widely available before 2009;

===============================================

March 18, 2008 ­

Based on the VSD and Merck studies that suggested an elevated risk for

febrile seizures after the first dose of MMRV vaccine, the ACIP voted to

change the preference language for the MMRV vaccine at its February 27,

2008, meeting. This change took into account the availability of

alternative options for vaccination against measles, mumps, rubella, and

varicella and the limited supply of MMRV vaccine because of manufacturing

constraints unrelated to vaccine safety or efficacy.

The updated ACIP recommendation now reads as follows: " Combination

MMRV vaccine is approved for use among healthy children aged 12 months-12

years. MMRV vaccine is indicated for simultaneous vaccination against

measles, mumps, rubella, and varicella. ACIP does not express a

preference for use of MMRV vaccine over separate injections of equivalent

component vaccines (i.e., MMR vaccine and varicella

vaccine). "

http://www.medscape.com/viewarticle/571595

=========================================

FDA

February 27, 2008

OUR STN: BL125108/266

Merck & Co., Inc.

Attention: Dekleva, Ph.D.

UG2D-68

P.O. Box 1000

North Wales, PA 19454-1099

Dear Dr. Dekleva,

We have approved your request to supplement your biologics license

application for Measles, Mumps, Rubella and Varicella Virus Vaccine Live

(ProQuad®), to include revisions to the package insert.

The Adverse Reactions section of the label has been revised to include

two adverse events, encephalitis and epididymitis, to reflect updated

data from post-marketing surveillance reports. Information regarding the

potential risk of febrile seizures following ProQuad® administration has

also been added to this section.

Please provide a PDF-format electronic version of all final printed

labeling and implementation information at the time of use.

We will include information contained in the above-referenced supplement

in your Biologics License Application File.

Sincerely yours,

/Loris D. McVittie, Ph.D./

Loris D. McVittie, Ph.D.

Acting Director

Division of Vaccines and Related Products Applications

Office of Vaccines Research and Review

Center for Biologics Evaluation and Research

Attachment: Approved Final Draft Labeling

Â

http://www.fda.gov/CBER/approvltr/proquad022708L.htm

--------------------------------------------------------

Sheri Nakken, former R.N., MA, Hahnemannian Homeopath

Vaccination Information & Choice Network, Nevada City CA & Wales

UK

Vaccines -

http://www.wellwithin1.com/vaccine.htm

Vaccine Dangers & Homeopathy Online/email courses

--------------------------------------------------------

Sheri Nakken, former R.N., MA, Hahnemannian

Homeopath

Vaccination Information & Choice Network, Nevada City CA & Wales

UK

Vaccines -

http://www.wellwithin1.com/vaccine.htm

Vaccine Dangers & Homeopathy Online/email courses